Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Barriers
Beyond Scholars
Community Table
GetInsulin.org
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
News
Mark Cuban’s Cost Plus Drugs Makes Diabetes Products More Affordable
Mark Cuban's Cost Plus Drugs Company just announced that they offer Janssen's Invokana, Invokamet and Invokamet XR for type 2 diabetes.
Why Diabetes Should be Screened by Age Instead of Weight
Many cases of diabetes may be missed by screening only by weight instead of age, especially for some racial and ethnic groups.
California Partners with Civica Rx to Make More Affordable Insulin
California has signed a contract with Civica Rx to make more affordable insulin for Americans with diabetes. Here’s what you should know about their partnership, CalRx.
Novo Nordisk to Slash Insulin Prices by over 65%
Novo Nordisk announced that starting January 1st, 2024 they will be lowering the list price of several of their insulins by 65-70%.
This New App is Designed to Make Tracking Your Insulin Easier
If you use Lilly brand insulin, this new connected platform is designed to make tracking your diabetes data a lot easier.
Freestyle Libre 3 Now Available in Pharmacies Across the U.S.
On Thursday, Oct. 6, 2022, Abbott—makers of the Freestyle Libre 3—announced that the product is now available in pharmacies nationwide.
Despite Universal Healthcare, Diabetes Disparities Persists in the United Kingdom
To address the racial and economic divide in diabetes technology use, a top U.K. diabetes specialist urges a change in pump and CGM training.
Coverage of Dexcom G6 CGM Now Improved with TRICARE
TRICARE healthcare members can now receive the Dexcom G6 continuous glucose monitor (CGM) under pharmacy benefits.
The Affordable Insulin Now Act: A Step Toward Federal Legislation
The Affordable Insulin Now Act, if passed in its current form, could help bring down the cost of insulin for millions of insured people with diabetes.
FreeStyle Libre 2 Now More Easily Accessible for Military Members Through TRICARE
Military members with TRICARE now have easier access to Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM).
COVID-19 Pushes FDA Approval of Breakthrough Device Designation for Dexcom CGM in Hospital Settings
The FDA has granted Breakthrough Device Designation for Dexcom CGM in hospital settings after the pandemic highlighted essential care needs for patients with diabetes.
Eversense E3 Continuous Glucose Monitor Gains FDA Approval, Offers Extended Wear-Time
The Eversense E3 continuous glucose monitor (CGM) is an exciting advancement for the diabetes community, with improved wear-time and accuracy.
Inside the Drug Pricing Investigation from the House Oversight and Reform Committee
The results of the most recent report from the committee make things clear for the United States — the need for access to affordable healthcare is direr than ever.
The Latinx Diabetes Initiative Provides Culturally Tailored Care To Latinx Patients With Diabetes
Andreina Millan Ferro is centering culturally sensitive diabetes care for Latinx patients with diabetes at the Latinx Diabetes Initiative.
Yarishdy Mora Is Empowering Youth Through Diabetes Education In Mexico
Yarishdy Mora is the director of the Youth Health Program for Project HOPE in Mexico. She creates platforms that help youth learn about diabetes.
Posts navigation
←
Newer
Posts
1
2
3
…
11
Older
Posts
→